Legislature(2023 - 2024)SENATE FINANCE 532
05/17/2023 09:00 AM Senate FINANCE
Note: the audio and video recordings are distinct records and are obtained from different sources. As such there may be key differences between the two. The audio recordings are captured by our records offices as the official record of the meeting and will have more accurate timestamps. Use the icons to switch between them.
Audio | Topic |
---|---|
Start | |
HB112 | |
Adjourn |
* first hearing in first committee of referral
+ teleconferenced
= bill was previously heard/scheduled
+ teleconferenced
= bill was previously heard/scheduled
+ | TELECONFERENCED | ||
*+ | HB 112 | TELECONFERENCED | |
CS FOR HOUSE BILL NO. 112(L&C) am "An Act relating to the Board of Pharmacy; relating to the practice of pharmacy; relating to pharmacies; relating to prescription drug manufacturers; relating to licensing and registration requirements for certain wholesale drug distributors; relating to prescriptions for epinephrine; relating to the administration of epinephrine; and providing for an effective date." 11:22:16 AM AT EASE 11:22:43 AM RECONVENED 11:23:27 AM REPRESENTATIVE JUSTIN RUFFRIDGE, SPONSOR, introduced the legislation. He explained that the bill was the exact copy of SB 94. He stated that it was important to align the statutes and regulations with federal laws related to the Drug Chain and Securities Supply Act, which would go into effect on November 7, 2023. He stated that the intent was to secure the drug chain for the maintenance of the security of medications. He noted that there were a number of other issues within the bill, as it was a multi-year effort to draft the legislation to align the regulations to the modern pharmacy practices. 11:25:49 AM Co-Chair Olson recalled a staffer who died from a bee sting, because there was not immediate access to an epi- pen. Senator Kiehl wondered whether the bill matched the current changes in the Senate version of the bill. Representative Ruffridge replied in the affirmative. KEN ALPER, STAFF, SENATOR DONNY OLSON, reiterated the history of the legislation within the committee. He noted that the fiscal note had a small general fund amount, but was dependent on the final budget process. Co-Chair Olson wondered how the bill would make the state incompliance with the current federal requirements. Representative Ruffridge replied that the Drug Chain, Security, and Supply Act was passed in 2013 into federal law. The act gave states ten years to get into compliance with that law. He noted that it was sweeping legislation in regards to how drug products were sent to wholesalers and how those drugs were delivered to pharmacies. He stated that the bill required additional oversight to ensure that those regulations were met. Senator Kiehl MOVED to REPORT CSHB 112(L&C)am out of committee with individual recommendations and attached fiscal impact note. There being NO OBJECTION, it was so ordered. 11:29:33 AM RECESSED [This meeting was adjourned at 6:23 p.m.]
Document Name | Date/Time | Subjects |
---|---|---|
HB 112 Sectional Analysis ver CS 5.16.23.pdf |
SFIN 5/16/2023 1:30:00 PM SFIN 5/17/2023 9:00:00 AM |
HB 112 |
HB 112 Support as of 4.20.23 Redacted.pdf |
SFIN 5/16/2023 1:30:00 PM SFIN 5/17/2023 9:00:00 AM |
HB 112 |
HB 112 Summary of Changes CS 5.16.23.pdf |
SFIN 5/16/2023 1:30:00 PM SFIN 5/17/2023 9:00:00 AM |
HB 112 |
HB 112 Sponsor Statement Version CS 5.16.23.pdf |
SFIN 5/16/2023 1:30:00 PM SFIN 5/17/2023 9:00:00 AM |
HB 112 |